1-(4-methylbenzyl)-N-(2-(pyridin-3-yloxy)phenyl)pyrrolidine-2-carboxamide

ID: ALA4877613

PubChem CID: 45248164

Max Phase: Preclinical

Molecular Formula: C24H25N3O2

Molecular Weight: 387.48

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(CN2CCCC2C(=O)Nc2ccccc2Oc2cccnc2)cc1

Standard InChI:  InChI=1S/C24H25N3O2/c1-18-10-12-19(13-11-18)17-27-15-5-8-22(27)24(28)26-21-7-2-3-9-23(21)29-20-6-4-14-25-16-20/h2-4,6-7,9-14,16,22H,5,8,15,17H2,1H3,(H,26,28)

Standard InChI Key:  CYCZYDSXTWKZGE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   11.9442   -3.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7614   -3.9621    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1700   -3.2544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5375   -3.2521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7210   -3.2518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3116   -3.9600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7246   -4.6701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5397   -4.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9861   -3.2572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3946   -2.5503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9859   -1.8416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1645   -1.8443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7597   -2.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3933   -3.9657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2105   -3.9672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6178   -4.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6205   -3.2603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2837   -5.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8899   -5.9690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5985   -5.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4300   -4.7621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9777   -4.1557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7768   -4.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0246   -5.1051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8229   -5.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3715   -4.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1164   -3.8888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3187   -3.7212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1708   -4.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  1  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  1  1  0
  3  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
  9 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
M  END

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 387.48Molecular Weight (Monoisotopic): 387.1947AlogP: 4.79#Rotatable Bonds: 6
Polar Surface Area: 54.46Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.80CX Basic pKa: 7.30CX LogP: 4.24CX LogD: 3.99
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.66Np Likeness Score: -1.66

References

1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T..  (2021)  Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.,  43  [PMID:33887438] [10.1016/j.bmcl.2021.128048]

Source